These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34392518)

  • 21. Preoperative skin antiseptics for prevention of cardiac implantable electronic device infections: a historical-controlled interventional trial comparing aqueous against alcoholic povidone-iodine solutions.
    Da Costa A; Tulane C; Dauphinot V; Terreaux J; Romeyer-Bouchard C; Gate-Martinet A; Levallois M; Isaaz K
    Europace; 2015 Jul; 17(7):1092-8. PubMed ID: 25917024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-Effectiveness Analyses of an Absorbable Antibacterial Envelope for Use in Patients at Increased Risk of Cardiac Implantable Electronic Device Infection in Germany, Italy, and England.
    Boriani G; Kennergren C; Tarakji KG; Wright DJ; Ahmed FZ; McComb JM; Goette A; Blum T; Biffi M; Green M; Shore J; Carion PL; Wilkoff BL
    Value Health; 2021 Jul; 24(7):930-938. PubMed ID: 34243836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac implantable electronic device infections: incidence, risk factors, and the effect of the AigisRx antibacterial envelope.
    Mittal S; Shaw RE; Michel K; Palekar R; Arshad A; Musat D; Preminger M; Sichrovsky T; Steinberg JS
    Heart Rhythm; 2014 Apr; 11(4):595-601. PubMed ID: 24333543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Device-related infection and mortality in patients with chronic kidney disease receiving cardiac implantable electronic devices: a propensity score-matched cohort study.
    Wu PJ; Chen HC; Fang YN; Chong SZ; Chen YL; Chen MC
    BMC Infect Dis; 2023 Nov; 23(1):787. PubMed ID: 37957553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular implantable electronic device infections in left ventricular assist device recipients.
    Riaz T; Nienaber JJ; Baddour LM; Walker RC; Park SJ; Sohail MR
    Pacing Clin Electrophysiol; 2014 Feb; 37(2):225-30. PubMed ID: 23998684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors for Infections Involving Cardiac Implanted Electronic Devices.
    Birnie DH; Wang J; Alings M; Philippon F; Parkash R; Manlucu J; Angaran P; Rinne C; Coutu B; Low RA; Essebag V; Morillo C; Redfearn D; Toal S; Becker G; Degrâce M; Thibault B; Crystal E; Tung S; LeMaitre J; Sultan O; Bennett M; Bashir J; Ayala-Paredes F; Gervais P; Rioux L; Hemels MEW; Bouwels LHR; Exner DV; Dorian P; Connolly SJ; Longtin Y; Krahn AD
    J Am Coll Cardiol; 2019 Dec; 74(23):2845-2854. PubMed ID: 31806127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in cardiac implantable electronic device infection prevention: should we push the envelope?
    Lambert CT; Wilkoff BL; Tarakji KG
    Future Cardiol; 2018 Sep; 14(5):359-366. PubMed ID: 30062906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for cardiac implantable electronic device infections: a nationwide Danish study.
    Olsen T; Jørgensen OD; Nielsen JC; Thøgersen AM; Philbert BT; Frausing MHJP; Sandgaard NCF; Johansen JB
    Eur Heart J; 2022 Dec; 43(47):4946-4956. PubMed ID: 36263789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of Cardiac Implantable Electronic Device Infections: Single Operator Technique with Use of Povidone-Iodine, Double Gloving, Meticulous Aseptic/Antiseptic Measures and Antibiotic Prophylaxis.
    Manolis AS; Melita H
    Pacing Clin Electrophysiol; 2017 Jan; 40(1):26-34. PubMed ID: 27996097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects.
    Kolek MJ; Patel NJ; Clair WK; Whalen SP; Rottman JN; Kanagasundram A; Shen ST; Saavedra PJ; Estrada JC; Abraham RL; Ellis CR
    J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1111-6. PubMed ID: 26222980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
    Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection.
    Alshoubaki O; Al Darabaa Z; Odat O; Qubbaj A; Alhyari R; Alshare S; Ghanma I
    Med Arch; 2021 Feb; 75(1):56-60. PubMed ID: 34012201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial.
    Wilkoff BL; Boriani G; Mittal S; Poole JE; Kennergren C; Corey GR; Krahn AD; Schloss EJ; Gallastegui JL; Pickett RA; Evonich RF; Roark SF; Sorrentino DM; Sholevar DP; Cronin EM; Berman BJ; Riggio DW; Khan HH; Silver MT; Collier J; Eldadah Z; Holbrook R; Lande JD; Lexcen DR; Seshadri S; Tarakji KG
    Circ Arrhythm Electrophysiol; 2020 Oct; 13(10):e008503. PubMed ID: 32915063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategies to prevent infections associated with cardiovascular implantable electronic devices.
    Palraj BR; Farid S; Sohail MR
    Expert Rev Med Devices; 2017 May; 14(5):371-381. PubMed ID: 28434261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac implantable electronic device infections: the enemy that lurks beneath the skin.
    Margey R
    J Long Term Eff Med Implants; 2010; 20(3):203-17. PubMed ID: 21395519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention, Diagnosis, and Treatment of Cardiac Implantable Electronic Device Infections.
    Leung S; Danik S
    Curr Cardiol Rep; 2016 Jun; 18(6):58. PubMed ID: 27147510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of cardiac implantable electronic device infections in the United States: A population-based cohort study.
    Rennert-May E; Chew D; Lu S; Chu A; Kuriachan V; Somayaji R
    Heart Rhythm; 2020 Jul; 17(7):1125-1131. PubMed ID: 32087358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes of patients undergoing a cardiac implantable electronic device implantation following a recent non-device-related infection.
    Chen HC; Chen YL; Lee WC; Tsai TH; Pan KL; Lin YS; Chen MC
    J Hosp Infect; 2020 Jun; 105(2):272-279. PubMed ID: 32057789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of antibacterial envelope in prevention of cardiovascular implantable electronic device infections in high-risk patients: A systematic review and meta-analysis.
    Ullah W; Nadeem N; Haq S; Thelmo FL; Abdullah HM; Haas DC
    Int J Cardiol; 2020 Sep; 315():51-56. PubMed ID: 32291170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New diagnostic pathways urgently needed. Protocol of PET Guidance I pilot study: positron emission tomography in suspected cardiac implantable electronic device-related infection.
    Marciniak-Emmons MB; Sterliński M; Syska P; Maciąg A; Farkowski MM; Firek B; Dziuk M; Zając D; Pytkowski M; Szwed H
    Kardiol Pol; 2016; 74(1):47-52. PubMed ID: 26101020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.